Biostatistician @WCVID @TheKids_AU interested in Bayesian adaptive trial design and causal modelling. Now a PhD student so I can use the student parking.
Congratulations to the PICOBOO Investigator Team for their paper published @BioMedCentral - 'Statistical considerations for the platform trial in #COVID19#vaccine priming and boosting' led by first-author Michael Dymock
https://t.co/qDf0sKeVwV
2327 citations, untold millions of dollars spent chasing a non-existent result based on manipulated images that were easily spotted in post-pub peer review.
In addition to retraction, it would be nice to prevent things like this in the future. Can haz quality assurance plz?
@gladymar85 @GKountourides@rlmcelreath It worked very well in a group of about 20 at any one time just taking it in turns to present. Depending on the group and the collective background knowledge I would suggest a lecture a week to start but then allow for more time to digest the latter sections.
On Day 4 @ASC2023 ASC/OZCOTS Keynote speaker Professor Sir David Spiegelhalter discussed Trust vs Trustworthiness of communication of data-derived evidence with the audiences.
Tragically, kids are often left out of #clinicaltrials.
Not so for the @snap_trial, which brings data from adults and kids together using a sophisticated #Bayesian model.
Our new statistical 'blueprint' details how we make it work (so you can too!).
https://t.co/65ZoYRBeVl
New blog article on use of historical control data in RCTs. Trust the historical data sample size but not what it’s estimating. Bayes provides a simple approach to explicitly model bias from historical controls. https://t.co/nFV88W1O7B @vandy_biostat #Statistics#clinicaltrials
Congratulations to the four early-career recipients of registration scholarships to attend #ASC2023. The WA branch are proud to support Lucy Conran, @mdymock25 , @ShihChingFu, and Alistair Martin, as they present their work in Wollongong in December. @ASC2023@StatSocAus
Our recent @PLOSCompBiol paper shows how modelers and clinicians can co-build a causal BN that helps determine the pathogens responsible for a child's pneumonia, offering the opportunity to inform better clinical decision making and patient outcomes. https://t.co/gqjEkifQq6
Australians living with #HepC are being urged to join a new trial exploring ways to encourage the use of life saving medication. Despite having been available for many years in Australia, over half of those living with #HepC are yet to be treated https://t.co/9RyxDQivpO
(1/2)
Congratulations to the incoming Branch Council elected this week: @dr_njarmstrong (Pres.), John Henstridge (VP), @BAT_AUS95 (Treas.), @ShihChingFu (Sec.), Lucy Conran (@ssa_ecssn Rep.), Fiona Scarff (Memb. Ofc.), and @mdymock25. Big thankyou to the past Council for their service.
Congratulations on the @ResAustralia win AusVaxSafety!
We are proud to lead the analytics as part of this fantastic national consortium at @NCIRS - well done to all involved! @telethonkids@snelling_tom@mdymock25
https://t.co/wxvX0GtJqy
Well done to biostatistician Michael Dymock - WA's only recipient of a @nhmrc postgraduate scholarship!
Over $7mill will be shared across 62 early career researchers - congrats @mdymock25! @telethonkids@uwanews@UWAresearch
https://t.co/BrzslmmlcK
On the road for National #ScienceWeek! This week researchers like Biostatistician Michael are visiting schools across Perth to share their #STEM journeys & encourage kids to get hands on with #science! @telethonkids@Aus_ScienceWeek
Wonderful for @MichaelDymock2 to present the intricacies of CUSUM/PPA to detect vaccine safety signals at #CDIC2022. A great addition to improve confidence in vaccine safety and the timeliness of adverse event detection @WCVID@telethonkids@snelling_tom